Bengaluru's Pandorum Technologies teams up with Nucelion Therapeutics to scale its exosome-based therapeutic platform across ...

Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue regeneration, today announced a strategic collaboration with Hyderabad ...

Lymphatic malformations (LMs) are congenital vascular anomalies characterized by abnormal lymphatic development, leading to ...

Pandorum and Nucelion ink pact to manufacture exosome-based tissue regenerative therapy for ocular diseases in APAC markets: Our Bureau, Bengaluru Tuesday, January 6, 2026, 16:30 ...

Pandorum Technologies, a regenerative medicine company, on Tuesday announced a strategic collaboration with Hyderabad-based Nucelion Therapeutics to strengthen manufacturing capabilities for its ...

Evidence from multiple model systems supports a shift away from heme transport and toward metabolic dysfunction and oxidative stress as key drivers of TANGO2 deficiency.